Determinants of Overall and Progression-Free Survival of Nigerian Patients with Philadelphia-Positive Chronic Myeloid Leukemia

Table 2

Overall and progression-free survival (OS and PFS) of all 272 patients and of 205 patients in chronic phase (CP).

(a)

Variables	values, for all 272 adult patients
Survival statistics	OS	SE	PFS	SE
At 1 year	94%	0.016	89%	0.020
At 2 years	84%	0.027	77%	0.030
At 5 years	63%	0.052	54%	0.053
Median survival	Not reached yet

(b)

Variables	values, for 205 CP adult patients
Survival statistics	OS	SE	PFS	SE
At 1 year	97%	0.013	92%	0.020
At 2 years	87%	0.029	79%	0.030
At 5 years	68%	0.059	57%	0.053
Median survival	Not reached yet